EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data

Philipp Berg iD, Margarethe Heiden, Susanne Müller, Britta Meyer, Cornelia Witzenhausen, Gabriele Ruppert-Seipp iD, Sarah Kehr iD, Markus B Funk iD

Vox Sanguinis · 2024-09 · 119 (9) · 953-962

DOI: 10.1111/vox.13694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 18.06.2024. Verfasst von Philipp Berg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut (PEI), Langen, Germany. Hauptthemen laut MEDLINE: Blood Safety, Transfusion Reaction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Haemovigilance (HV) systems aim to improve transfusion outcomes in patients and donor safety. An important question for blood regulators is how to ensure an effective HV system. Materials and Methods We retrospectively analysed the HV reports submitted to Paul‐Ehrlich‐Institut over the last two decades.

Results

Between 2011 and 2020, 50.86 million units of blood components were used, and 8931 suspected serious donor and recipient adverse reactions (SARs), 874 serious adverse events (SAEs) and 12,073 donor look‐backs were reported. Following implementation of specific risk‐minimization measures (RMMs) between 2000 and 2010, SAR reporting rates decreased for transfusion‐transmitted viral infections (TTVIs), transfusion‐related acute lung injury (TRALI) and transfusion‐transmitted bacterial infections (TTBIs), while increasing for other serious adverse transfusion reactions. Within this decade, the overall blood component use decreased.

Conclusion

Long‐term data collection forms the basis to establish trends and changes in reporting and to evaluate the effect of RMM. Standardized criteria for reaction types, seriousness and imputability assessments and availability of a denominator are important elements. Central data collection and independent assessment allow for monitoring HV data in a nationwide context over time. Stakeholder involvement and transparent feedback on the benefit of RMM will help to achieve the objectives of HV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood SafetyTransfusion ReactionHumansRetrospective StudiesGermanyBlood TransfusionVirus DiseasesTransfusion-Related Acute Lung InjuryBlood Donors

Stichwörter der Autor:innen

adverse reactionsblood safety surveillancehaemovigilancetransfusion complications

Autor:innen und Institutionen

  • Division Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut (PEI), Langen, Germany.

ORCID-Profile: Philipp Berg, Gabriele Ruppert-Seipp, Sarah Kehr, Markus B Funk

Zitieren

APA

Berg, P., Heiden, M., Müller, S., Meyer, B., Witzenhausen, C., Ruppert-Seipp, G., Kehr, S., & Funk, M. B. (2024). A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data. Vox Sanguinis, 119(9), 953-962. https://doi.org/10.1111/vox.13694

Vancouver

Berg P, Heiden M, Müller S, Meyer B, Witzenhausen C, Ruppert-Seipp G, et al. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data. Vox Sanguinis. 2024;119(9):953-962. doi:10.1111/vox.13694

BibTeX
@article{Berg2024,
  author = {Berg, Philipp and Heiden, Margarethe and Müller, Susanne and Meyer, Britta and Witzenhausen, Cornelia and Ruppert-Seipp, Gabriele and Kehr, Sarah and Funk, Markus B},
  title = {A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data},
  journal = {Vox Sanguinis},
  year = {2024},
  volume = {119},
  number = {9},
  pages = {953--962},
  doi = {10.1111/vox.13694}
}
Kostenlos starten →